It’s that time of year again, and we would like to remind all individuals living with MS of the importance of getting the new updated COVID vaccine and your annual…
Read More
We’re so grateful for our community’s support of the Rocky Mountain MS Center and of Saturday evening’s Gala. With their generosity and dedication to the MS Center, our supporters, sponsors and friends helped us exceed our fundraising goal and raise $400,000 — the most we’ve ever raised in four decades of Galas!
In this issue we’ve learned about the science behind stress, as well as the many different types of stress that can manifest in our lives. Managing these various forms of…
Elissa Berlinger is a Licensed Clinical Social Worker and MS Educator. She has been involved with the Rocky Mountain MS Center since 2010, after being diagnosed with MS. She received…
At the Rocky Mountain MS Center, we endorse a three-part treatment approach aimed at maximizing lifelong brain health and minimizing damage done by MS in the brain. The first component…
Stress is an ever-present force in our lives and deeply ingrained in the human experience. In this issue of InforMS, we explore the science of stress, untangle its many facets,…
Living with multiple sclerosis (MS) comes with its unique challenges, but being prepared for your visits with your neurology team can make a significant difference in managing your condition…
The Rocky Mountain MS Center’s Conversations on MS program, session recorded on October 4, 2023. Presented by Dr. Robert Gross of the Rocky Mountain MS Center. LINKS MENTIONED IN…
In this webinar, Dr. John Corboy and Dr. Daniel Pastula discuss recently published data that shows an increased risk of severe West Nile Virus infection among patients taking certain medications…
The U.S. Food and Drug Administration (FDA) recently approved Tyruko (natalizumab-sztn, made by Sandoz, a division of the Novartis group). Tyruko is the first biosimilar disease-modifying therapy (DMT) for individuals…